Kraig Biocraft Laboratories, Inc.
KBLB- Exchange
- OTC
- Industry
- Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
- SEC CIK
- 0001413119
No open-market purchases or sales by Kraig Biocraft Laboratories, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KBLB, Q2 2026
No superinvestor reported holding KBLB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Kraig Biocraft Laboratories, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2022 (view filing) | Jul 19-20 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −170.0K | – | – | −0.1%201.6M after | 2 lots |
| Jul 19, 2022 (view filing) | Jul 15-18 | 4 days | Thompson Kimberly KraigCEO & CFO | SSale | −129.9K | – | – | −0.1%201.8M after | 2 lots |
| Jul 15, 2022 (view filing) | Jul 13 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −11.5K | – | – | 0.0%201.9M after | |
| Jul 13, 2022 (view filing) | Jul 11 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −100.0K | – | – | 0.0%201.9M after | |
| Jul 11, 2022 (view filing) | Jul 7-8 | 4 days | Thompson Kimberly KraigCEO & CFO | SSale | −60.0K | – | – | 0.0%202.0M after | 2 lots |
| Jul 7, 2022 (view filing) | Jul 5-6 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −80.0K | – | – | 0.0%202.1M after | 2 lots |
| Jul 1, 2022 (view filing) | Jun 29 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −20.0K | – | – | 0.0%202.1M after | |
| Jun 29, 2022 (view filing) | Jun 27-28 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −80.0K | – | – | 0.0%202.2M after | 2 lots |
| Jun 24, 2022 (view filing) | Jun 23-24 | 1 day | Thompson Kimberly KraigCEO & CFO | SSale | −110.0K | – | – | −0.1%202.2M after | 2 lots |
| Jun 23, 2022 (view filing) | Jun 21-22 | 2 days | Thompson Kimberly KraigCEO & CFO | SSale | −210.0K | – | – | −0.1%202.3M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Kraig Biocraft Laboratories, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding KBLB in 13F filings for Q2 2026.